These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 25193104)
1. Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. Terry FE; Moise L; Martin RF; Torres M; Pilotte N; Williams SA; De Groot AS Expert Rev Vaccines; 2015 Jan; 14(1):21-35. PubMed ID: 25193104 [TBL] [Abstract][Full Text] [Related]
2. Vaccines for neglected, emerging and re-emerging diseases. Madhav A; Mehrotra T; Sinha P; Mutreja A Semin Immunol; 2020 Aug; 50():101423. PubMed ID: 33250352 [TBL] [Abstract][Full Text] [Related]
3. Neglected tropical disease and emerging infectious disease: an analysis of the history, promise and constraints of two worldviews. Jackson Y; Stephenson N Glob Public Health; 2014; 9(9):995-1007. PubMed ID: 25096397 [TBL] [Abstract][Full Text] [Related]
5. Developing and financing neglected disease vaccines in our new era of "blue marble health" and the anthropocene epoch. Hotez PJ Vaccine; 2017 Sep; 35(40):5403-5405. PubMed ID: 28262333 [TBL] [Abstract][Full Text] [Related]
6. Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design. Kazi A; Chuah C; Majeed ABA; Leow CH; Lim BH; Leow CY Pathog Glob Health; 2018 May; 112(3):123-131. PubMed ID: 29528265 [TBL] [Abstract][Full Text] [Related]
7. The global fight to develop antipoverty vaccines in the anti-vaccine era. Hotez PJ Hum Vaccin Immunother; 2018; 14(9):2128-2131. PubMed ID: 29393710 [TBL] [Abstract][Full Text] [Related]
8. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. De Groot AS; Moise L; Terry F; Gutierrez AH; Hindocha P; Richard G; Hoft DF; Ross TM; Noe AR; Takahashi Y; Kotraiah V; Silk SE; Nielsen CM; Minassian AM; Ashfield R; Ardito M; Draper SJ; Martin WD Front Immunol; 2020; 11():442. PubMed ID: 32318055 [TBL] [Abstract][Full Text] [Related]
9. Making vaccines "on demand": a potential solution for emerging pathogens and biodefense? De Groot AS; Einck L; Moise L; Chambers M; Ballantyne J; Malone RW; Ardito M; Martin W Hum Vaccin Immunother; 2013 Sep; 9(9):1877-84. PubMed ID: 23877094 [TBL] [Abstract][Full Text] [Related]
10. Strategies supporting the prevention and control of neglected tropical diseases during and beyond the COVID-19 pandemic. Ehrenberg JP; Zhou XN; Fontes G; Rocha EMM; Tanner M; Utzinger J Infect Dis Poverty; 2020 Jul; 9(1):86. PubMed ID: 32646512 [TBL] [Abstract][Full Text] [Related]
11. Developing vaccines for neglected and emerging infectious diseases. Yamey G BMJ; 2021 Feb; 372():n373. PubMed ID: 33568361 [No Abstract] [Full Text] [Related]
12. Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Mackey TK; Liang BA; Cuomo R; Hafen R; Brouwer KC; Lee DE Clin Microbiol Rev; 2014 Oct; 27(4):949-79. PubMed ID: 25278579 [TBL] [Abstract][Full Text] [Related]
13. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Moise L; Gutierrez A; Kibria F; Martin R; Tassone R; Liu R; Terry F; Martin B; De Groot AS Hum Vaccin Immunother; 2015; 11(9):2312-21. PubMed ID: 26155959 [TBL] [Abstract][Full Text] [Related]
15. Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases. Oh SJ; Choi YK; Shin OS Yonsei Med J; 2018 Mar; 59(2):176-186. PubMed ID: 29436184 [TBL] [Abstract][Full Text] [Related]
16. Immune camouflage: relevance to vaccines and human immunology. De Groot AS; Moise L; Liu R; Gutierrez AH; Tassone R; Bailey-Kellogg C; Martin W Hum Vaccin Immunother; 2014; 10(12):3570-5. PubMed ID: 25483703 [TBL] [Abstract][Full Text] [Related]